HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Semaxinib (SU5416)

Also Known As:
SU5416; 3-(2,4-dimethylpyrrol-5-yl)methylidene-indolin-2-one; SU 5416; SU-5416; Sugen 5416
Networked: 396 relevant articles (35 outcomes, 74 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Voelkel, Norbert F: 24 articles (01/2021 - 04/2002)
2. Weissmann, Norbert: 10 articles (01/2021 - 09/2008)
3. Farkas, Laszlo: 10 articles (01/2019 - 10/2012)
4. McMurtry, Ivan F: 10 articles (01/2019 - 08/2004)
5. Tuder, Rubin M: 9 articles (12/2022 - 04/2002)
6. Seeger, Werner: 9 articles (01/2022 - 09/2008)
7. Kraskauskas, Donatas: 9 articles (03/2015 - 03/2007)
8. Goncharova, Elena A: 8 articles (01/2022 - 02/2016)
9. Grimminger, Friedrich: 8 articles (01/2021 - 09/2008)
10. Sakao, Seiichiro: 7 articles (05/2022 - 11/2007)

Related Diseases

1. Hypoxia (Hypoxemia)
2. Neoplasms (Cancer)
3. Pulmonary Arterial Hypertension
4. Vascular Remodeling
5. Ovarian Neoplasms (Ovarian Cancer)

Related Drugs and Biologics

1. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
2. Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
3. Angiogenesis Inhibitors
4. Tyrosine Kinase Inhibitors
5. Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
6. orantinib (SU6668)
7. Paclitaxel (Taxol)
8. selexipag
9. Sildenafil Citrate (Viagra)
10. Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Radiotherapy
4. Pneumonectomy (Lung Volume Reduction)
5. Subcutaneous Injections